ClickHere / Shutterstock.com
For those who can draw an informative patent map and work out a good navigational route through the complexities, there is an opportunity to gain significant competitive advantages through making the right partnerships, argue Quentin Tannock and Anna Duch.
The field of personalised medicine is diverse, and a dialogue with interested technology, patent and business experts needs to begin.
The US Food and Drug Administration’s Center for Drug Evaluation and Research has defined personalised medicine as “... using genetic or other biomarker information to make treatment decisions about patients”. The European Commission uses the term personalised medicine to refer to “a medical model using molecular profiling for tailoring the right therapeutic strategy for the right person at the right time, and/or to determine the predisposition to disease and/or to deliver timely and targeted prevention”.
Using either definition, personalised medicine includes a broad range of processes and technologies, across aspects of diagnostics, data analysis, treatments, treatment monitoring and related areas. We have summarised selected personalised medicine areas and indicated some interrelationships between these areas in Figure 1. These areas feature the application of both pre-existing technologies and emerging innovations, all of which can be the subject of patent applications.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
European Patent Office
George Washington Law School
Kirkland & Ellis International LLP
Marks & Clerk
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
The United States Patent and Trademark Office (USPTO)
World Intellectual Property Office
medicine; pharmaceuticals; FDA; IP Landscape; patents